A University of Calgary diabetes researcher, Cory Toth, who told us earlier this year that he would cease publishing in the scientific literature, has two more retractions, making seven.
Both appear in Neurobiology of Disease. Here’s the notice for “Differential impact of diabetes and hypertension in the brain: Adverse effects in white matter:”
Continue reading Diabetes researcher Cory Toth up to seven retractions
A paper about a protein being used — unapproved by health agencies — to treat diseases including cancer and autism has been retracted.
Here’s the notice from the International Journal of Cancer about a 2007 paper purporting to show that the substance, GcMAF, is useful against breast cancer: Continue reading Paper about widely touted but unapproved “cure” for cancer, autism retracted
A group of researchers in China has lost their paper on liver cancer after the first author admitted to duplication, also known, inelegantly, as self-plagiarism.
The paper, “Glycyrrhetinic acid-modified chitosan nanoparticles enhanced the effect of 5-fluorouracil in murine liver cancer model via regulatory T-cells,” appeared in the July 2013 issue of the Journal of Drug Design, Development and Therapy, a Dove Press title.
According to the abstract: Continue reading “Lack of experience and understanding” forces duplication retractions of liver cancer paper
After typing up 96 citations, researchers from the National Institute for Digestive Diseases, I.R.C.C.S. “S. de Bellis,” in Bari, Italy, apparently ran out of steam for the last five, earning themselves a retraction for plagiarism in a literature review of the effects of probiotics on intestinal cancer.
Here’s the notice for “Intestinal Microbiota, Probiotics and Human Gastrointestinal Cancers,” from the Journal of Gastrointestinal Cancer: Continue reading Yogurt to be kidding me: Five articles plagiarized in one retracted paper
Guangwen Tang, a rice researcher at Tufts University, landed in hot water in 2012 after her team was accused of feeding Chinese children genetically modified Golden Rice without having obtained informed consent from the parents.
Now, she’s suing both Tufts and the American Journal of Clinical Nutrition, which reportedly is retracting a paper, “ß-carotene in Golden Rice is as good as p-carotene in oil at providing vitamin A to children,” based on the federally funded research, claiming that the retraction would constitute defamation. (That retraction hasn’t happened yet.)
This isn’t the first time we’ve heard the retraction = defamation line. Readers might remember Ariel Fernandez, who threatened to sue us for writing about an expression of concern. Maybe a course on the Streisand Effect should be mandatory for PhD students?
Continue reading Rice researcher in ethics scrape threatens journal with lawsuit over coming retraction
The authors of a 2012 paper in the journal Interface have had the journal issue an expression of concern about it after issues with “some of the data and methods” came to light.
Here’s the expression of concern for “What makes an accurate and reliable subject-specific finite element model? A case study of an elephant femur:” Continue reading Authors issue their own expression of concern about elephant femur paper
PLOS ONE has retracted a 2012 article by a group of breast cancer researchers after another scientist — a leading U.S. oncologist — objected that the data came from his lab.
The paper, “GREB1 Functions as a Growth Promoter and Is Modulated by IL6/STAT3 in Breast Cancer,” came from a team composed of researchers at the Morehouse School of Medicine, Xavier University of Louisiana and the University of Miami School of Medicine. It purported to find that: Continue reading PLOS ONE retracts breast cancer genetics paper after claim of misappropriated data
A group of urologists in China has lost their 2012 paper in the Journal of Surgical Research because one of the authors was evidently rather naughty.
The article, “Is the impact of the extent of lymphadenectomy in radical prostatectomy related to the disease risk? A single center prospective study,” purported to show that: Continue reading Misconduct prompts retraction of prostatectomy paper
Lawsuits are usually dry and boring, so it’s always fun to read one with a little life.
Here’s one of those: CrossFit, the fitness program famous for its brief, strenuous exercises and passionate devotees, is suing the National Strength and Conditioning Association (NCSA), which it considers its staid competitor for the nation’s sweat and cash.
According to CrossFit, the NSCA published a study with a “falsified rate of injury,” “in an effort to portray CrossFit as ‘dangerous’ and therefore a fitness program that should be avoided.”
No matter that the study, published in NSCA’s official research journal, the Journal of Strength and Conditioning Research, concluded overall that CrossFit is a useful form of exercise. The suit says that the authors fudged a few statistics about participants’ injuries. Here’s the relevant section from the paper, titled “Crossfit-based high-intensity power training improves maximal aerobic fitness and body composition:”
Researchers at Qingdao University have fully retracted a paper originally published in Molecular Medicine Reports with a clear, detailed outline of what went wrong and how they discovered the error.
Here’s the notice for “Generation of induced pluripotent stem cells using skin fibroblasts from patients with myocardial infarction under feeder-free conditions:”